ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $221,000 | +10.0% | 4,260 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $201,000 | -33.7% | 4,260 | 0.0% | 0.02% | -21.7% |
| Q1 2022 | $303,000 | -5.0% | 4,260 | 0.0% | 0.02% | -4.2% |
| Q4 2021 | $319,000 | +51.9% | 4,260 | -10.9% | 0.02% | +41.2% |
| Q2 2021 | $210,000 | -11.0% | 4,780 | 0.0% | 0.02% | -19.0% |
| Q1 2021 | $236,000 | +17.4% | 4,780 | 0.0% | 0.02% | +5.0% |
| Q4 2020 | $201,000 | -8.2% | 4,780 | 0.0% | 0.02% | -16.7% |
| Q3 2020 | $219,000 | -13.1% | 4,780 | +59.9% | 0.02% | -42.9% |
| Q2 2019 | $252,000 | -11.9% | 2,990 | 0.0% | 0.04% | -16.0% |
| Q1 2019 | $286,000 | – | 2,990 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |